IL6 and pulmonary arterial hypertension: In the present study, we used 105 adipose-derived MSCs (a lower dosage than in previous studies [16]), obtained from healthy animals, and observed an attenuation of inflammatory markers, including IL-6, as in previous preclinical studies using MSCs in PAH animals.